The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
Moreover, due to its nauseating effect at higher doses (134136), PYY has not been pursued as an anti-obesity target
This test may help provide context for conversations about why certain patients respond differently to GLP-1 therapy, supporting more informed clinical decision-making
Wegovy (Semaglutide) Injection is an FDA-approved weight loss injection used to help you lose weight, reduce hunger, and feel full longer
doi: 10.3389/fnbeh.2026.1805953 Received 06 February 2026 Revised 13 March 2026 Accepted 13 March 2026 Published 13 April 2026 Volume 20 - 2026 Edited by Emmanuel Darcq, Institut National de la Sant et de la Recherche Mdicale (INSERM), France Reviewed by Zhe Zhao, Max Planck Florida Institute for Neuroscience (MPFI), United States Madhawi Aldhwayan, King Saud University, Saudi Arabia Updates Copyright 2026 OConnor